Genetic Architecture And Clinical Outcomes Of The Fredrickson-Levy-Lees Dyslipoproteinemias
View ORCID ProfileThomas Gilliland, View ORCID ProfileJaqueline S. Dron, View ORCID ProfileMargaret Sunitha Selvaraj, View ORCID ProfileMark Trinder, View ORCID ProfileKaavya Paruchuri, View ORCID ProfileSarah M. Urbut, View ORCID ProfileSara Haidermota, View ORCID ProfileRachel Bernardo, View ORCID ProfileMd Mesbah Uddin, View ORCID ProfileMichael C. Honigberg, View ORCID ProfileGina Peloso, View ORCID ProfilePradeep Natarajan
doi: https://doi.org/10.1101/2022.05.26.22275391
Thomas Gilliland
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
MDJaqueline S. Dron
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
PhDMargaret Sunitha Selvaraj
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
PhDMark Trinder
4Centre for Heart Lung Innovation, University of British Columbia, Vancouver
5Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard, Cambridge, Massachusetts
BAKaavya Paruchuri
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
MDSarah M. Urbut
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
MD PhDSara Haidermota
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
BARachel Bernardo
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
BSMd Mesbah Uddin
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
PhDMichael C. Honigberg
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
MD MPPGina Peloso
6Department of Biostatistics, Boston University School of Public Health, Boston, MA
PhDPradeep Natarajan
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
3Department of Medicine, Harvard Medical School, Boston, MA
MD, MMScArticle usage
Posted May 26, 2022.
Genetic Architecture And Clinical Outcomes Of The Fredrickson-Levy-Lees Dyslipoproteinemias
Thomas Gilliland, Jaqueline S. Dron, Margaret Sunitha Selvaraj, Mark Trinder, Kaavya Paruchuri, Sarah M. Urbut, Sara Haidermota, Rachel Bernardo, Md Mesbah Uddin, Michael C. Honigberg, Gina Peloso, Pradeep Natarajan
medRxiv 2022.05.26.22275391; doi: https://doi.org/10.1101/2022.05.26.22275391
Genetic Architecture And Clinical Outcomes Of The Fredrickson-Levy-Lees Dyslipoproteinemias
Thomas Gilliland, Jaqueline S. Dron, Margaret Sunitha Selvaraj, Mark Trinder, Kaavya Paruchuri, Sarah M. Urbut, Sara Haidermota, Rachel Bernardo, Md Mesbah Uddin, Michael C. Honigberg, Gina Peloso, Pradeep Natarajan
medRxiv 2022.05.26.22275391; doi: https://doi.org/10.1101/2022.05.26.22275391
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2823)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12516)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4396)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2830)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4153)
- Nursing (220)
- Nutrition (614)
- Oncology (2187)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6735)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)